Discontinued — last reported Q3 '25
Constellation Brands Equity Method Investments decreased by 26.9% to $170.60M in Q4 2023 compared to the prior quarter. Year-over-year, this metric declined by 74.3%, from $663.30M to $170.60M. Over 3 years (FY 2021 to FY 2024), Equity Method Investments shows a downward trend with a -60.6% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.66B | $2.82B | $2.76B | $2.69B | $2.53B | $833.40M | $771.40M | $663.30M | $291.30M | $277.10M | $233.30M | $170.60M |
| QoQ Change | — | +6.1% | -2.2% | -2.5% | -5.8% | -67.1% | -7.4% | -14.0% | -56.1% | -4.9% | -15.8% | -26.9% |
| YoY Change | — | — | — | — | -4.6% | -70.4% | -72.0% | -75.3% | -88.5% | -66.8% | -69.8% | -74.3% |
| Segment | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 |
|---|---|---|---|---|---|---|---|---|
| Wine and Spirits | $95.40M | $96.80M | $104.40M | $130.50M | $100.80M | $101.20M | $106.70M | $130.50M |
| Corporate Operations and Other | $567.90M | $194.50M | $172.70M | $102.80M | $69.80M | $25.70M | $22.00M | $20.50M |
| Total | $663.30M | $291.30M | $277.10M | $233.30M | $170.60M | — | — | — |
Corporate Operations and Other, Wine and Spirits were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.